Zevra Therapeutics annual revenue
2013
2014
2015
2018
2019
2020
2021
2022
2023
2024
2025
Zevra Therapeutics Revenue Growth & History (ZVRA)
Zevra Therapeutics reported $106.5M in revenue for fiscal 2025, an increase of 350.91% from the previous fiscal year.
View full Zevra Therapeutics company overviewZevra Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $106.5M | $82.9M | +350.91% |
| 2024 | 2024-12-31 | $23.6M | −$3.8M | −14.02% |
| 2023 | 2023-12-31 | $27.5M | $17.3M | +170.26% |
| 2022 | 2022-12-31 | $10.2M | −$18.5M | −64.53% |
| 2021 | 2021-12-31 | $28.6M | $15.4M | +115.61% |
| 2020 | 2020-12-31 | $13.3M | $449,000 | +3.50% |
| 2019 | 2019-12-31 | $12.8M | $12.8M | — |
| 2018 | 2018-12-31 | $0 | — | — |
| 2015 | 2015-12-31 | $0 | $0 | — |
| 2014 | 2014-12-31 | $0 | $0 | — |
| 2013 | 2013-12-31 | $0 | — | — |
Zevra Therapeutics quarterly revenue
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q3.18
Q1.19
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $39.7M | $13.8M | +53.25% |
| Q1 2026 | 2026-03-31 | $36.2M | $15.8M | +77.54% |
| Q4 2025 | 2025-12-31 | $34.1M | $22.1M | +183.36% |
| Q3 2025 | 2025-09-30 | $26.1M | $22.4M | +605.36% |
| Q2 2025 | 2025-06-30 | $25.9M | $21.4M | +481.73% |
| Q1 2025 | 2025-03-31 | $20.4M | $17.0M | +495.65% |
| Q4 2024 | 2024-12-31 | $12.0M | −$877,000 | −6.79% |
| Q3 2024 | 2024-09-30 | $3.7M | $800,000 | +27.63% |
| Q2 2024 | 2024-06-30 | $4.4M | −$4.0M | −47.47% |
| Q1 2024 | 2024-03-31 | $3.4M | $249,000 | +7.84% |
| Q4 2023 | 2023-12-31 | $12.9M | $10.9M | +538.97% |
| Q3 2023 | 2023-09-30 | $2.9M | $21,000 | +0.73% |
| Q2 2023 | 2023-06-30 | $8.5M | $7.2M | +551.54% |
| Q1 2023 | 2023-03-31 | $3.2M | −$789,000 | −19.90% |
| Q4 2022 | 2022-12-31 | $2.0M | −$560,000 | −21.69% |
| Q3 2022 | 2022-09-30 | $2.9M | $909,000 | +46.26% |
| Q2 2022 | 2022-06-30 | $1.3M | −$10.7M | −89.15% |
| Q1 2022 | 2022-03-31 | $4.0M | −$8.2M | −67.28% |
| Q4 2021 | 2021-12-31 | $2.6M | $216,000 | +9.13% |
| Q3 2021 | 2021-09-30 | $2.0M | $40,000 | +2.08% |
| Q2 2021 | 2021-06-30 | $12.0M | $5.1M | +73.51% |
| Q1 2021 | 2021-03-31 | $12.1M | $10.0M | +480.04% |
| Q4 2020 | 2020-12-31 | $2.4M | — | — |
| Q3 2020 | 2020-09-30 | $1.9M | −$9.5M | −83.21% |
| Q2 2020 | 2020-06-30 | $6.9M | — | — |
| Q1 2020 | 2020-03-31 | $2.1M | $2.1M | — |
| Q3 2019 | 2019-09-30 | $11.5M | $11.5M | — |
| Q1 2019 | 2019-03-31 | $0 | — | — |
| Q3 2018 | 2018-09-30 | $0 | — | — |
| Q1 2016 | 2016-03-31 | $0 | $0 | — |
| Q4 2015 | 2015-12-31 | $0 | $0 | — |
| Q3 2015 | 2015-09-30 | $0 | $0 | — |
| Q2 2015 | 2015-06-30 | $0 | $0 | — |
| Q1 2015 | 2015-03-31 | $0 | $0 | — |
| Q4 2014 | 2014-12-31 | $0 | — | — |
| Q3 2014 | 2014-09-30 | $0 | — | — |
| Q2 2014 | 2014-06-30 | $0 | — | — |
| Q1 2014 | 2014-03-31 | $0 | — | — |
Zevra Therapeutics revenue growth trends
Over the last five reported fiscal years, revenue grew from $13.3M to $106.5M, a compound annual growth rate of 51.62%. Zevra Therapeutics's latest reported quarter, Q2 2026, generated $39.7M in revenue, an increase of 53.25% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Zevra Therapeutics source filings ↗